day
emerg
reemerg
viral
infect
global
concern
especi
viral
infect
zoonot
import
affect
anim
health
also
affect
health
livelihood
small
margin
farmer
infect
respons
sever
econom
burden
agricultur
busi
crippl
foreign
domest
trade
anim
product
germplasm
devast
consequ
diseas
seen
recent
outbreak
avian
influenza
manipur
result
loss
total
valu
livestock
output
state
due
high
impact
zoonot
diseas
social
health
perspect
human
be
along
huge
econom
loss
outbreak
necessit
special
attent
term
diseas
diagnosi
prevent
creat
compet
diseas
prevent
treatment
control
continu
effort
requir
improv
diagnost
therapeut
prophylact
strategi
recent
develop
structur
biolog
pave
way
better
understand
biolog
behavior
peptid
protein
peptid
scienc
combin
alphabet
provid
novel
methodolog
diagnost
therapeut
prophylact
measur
superior
synthet
peptid
design
improv
practic
applic
methodolog
peptid
wider
biomed
applic
divers
area
like
drug
design
target
drug
deliveri
chemotherapi
serodiagnosi
oncolog
vaccinolog
approach
deal
infecti
diseas
also
found
similar
applic
metabol
inherit
disord
review
usag
superior
synthet
peptid
design
special
refer
multipl
antigen
peptid
map
viral
diagnosi
vaccin
possibl
antivir
intervent
discuss
differ
avail
peptid
dendrim
broadli
classifi
coval
non
coval
dendrim
map
polypeptid
base
dendrim
amphiphil
dendrim
coval
dendrim
wherea
poli
propyleneimin
mosaic
dendrim
peptid
lalanin
lphenylalanin
fall
categori
non
coval
dendrim
addit
peptid
dendrim
dendrimer
form
biolog
import
report
poli
aminodiamin
pamam
poli
propylen
imin
polyest
dendrim
metallodendrim
peptid
organ
super
molecular
design
dendrim
increas
bioavail
desir
action
found
effect
diseas
diagnosi
well
vivo
bioimag
comparison
linear
peptid
chain
peptid
molecul
conjug
differ
way
creat
branch
structur
dendrimer
form
multimer
form
dendrim
coval
noncoval
among
coval
dendrim
map
known
common
form
peptid
dendrim
shown
fig
compris
core
matrix
form
central
compon
branch
architectur
give
cascad
pennant
type
arrang
map
differ
amino
acid
use
core
format
ly
prefer
epsilon
amino
group
provid
flexibl
cascad
type
map
core
matrix
contain
two
three
level
geometr
branch
lysin
wherea
pennant
type
dendrim
contain
sequenti
linear
lysinyl
peptid
use
magnet
reson
imag
mri
protein
mimet
vaccin
direct
toward
bacteri
viral
parasit
pathogen
show
dynam
applic
map
peptid
dendrim
field
biomed
scienc
basic
advantag
map
flexibl
synthes
peptid
differ
structur
also
help
increas
load
capac
antigen
molecul
map
activ
use
immunodiagnosi
viral
diseas
like
acquir
immuno
defici
syndrom
aid
infecti
bursal
diseas
ibd
hepat
c
map
format
peptid
dendrim
protein
hiv
found
sensit
compar
linear
peptid
serodiagnosi
aid
upcom
promis
applic
map
dendrim
give
birth
newer
develop
peptid
base
diseas
diagnost
therapeut
peptid
dendrim
branch
architectur
higher
molecular
organ
peptid
stabl
structur
configur
commonli
use
drug
deliveri
vaccin
develop
diseas
diagnosi
classifi
accord
type
amino
acid
use
chain
arrang
final
three
dimension
structur
commonli
use
peptid
dendrim
develop
tam
use
lysin
core
copi
similar
differ
peptid
branch
format
dendrim
grow
two
reactiv
point
lysin
make
multiantigen
arm
found
favor
induct
immun
respons
altern
use
differ
amino
acid
like
prolin
arginin
glutam
acid
unnatur
amino
acid
ornithin
also
document
review
crespo
et
al
arginin
rich
dendrim
preferenti
use
intracellular
deliveri
biomolecul
nucleic
acid
polyglutam
dendrim
synthes
stack
amid
amid
hydrogen
bond
dendrim
oa
octa
silsesquioxan
core
promis
vector
fabric
smart
target
drug
deliveri
system
polyprolin
dendrim
structur
plastic
also
evalu
drug
deliveri
model
peptid
dendrim
found
effici
non
viral
drug
deliveri
gene
deliveri
non
invas
diagnost
method
synthesi
peptid
dendrim
form
tricki
cumbersom
procedur
involv
high
level
organ
peptid
chain
super
molecular
peptid
design
achiev
use
two
synthesi
strategi
name
converg
diverg
diverg
strategi
synthesi
occur
whole
stepwis
manner
synthesi
diverg
core
outward
singl
unit
altern
converg
strategi
dendron
synthes
separ
assembl
form
complet
dendrim
converg
strategi
dendrim
design
commonli
use
day
gene
deliveri
drug
deliveri
strategi
merit
demerit
diverg
strategi
prefer
smaller
product
synthesi
individu
compon
feasibl
avoid
case
heavi
branch
requir
wherea
converg
strategi
use
super
molecular
assembl
commonli
larger
size
intric
branch
pattern
separ
synthesi
unit
purif
make
process
difficult
peptid
chain
dendrim
usual
synthes
solid
phase
synthesi
method
amino
acid
sequenti
ad
one
one
c
termin
n
termin
peptid
anchor
solid
resin
bead
method
amino
acid
deriv
use
either
fmoc
boc
protect
reactiv
n
site
alpha
posit
wherea
side
chain
suitabl
block
differ
protect
group
remain
stabl
synthesi
procedur
diagnosi
infecti
diseas
play
import
role
better
health
manag
practic
diagnost
reagent
methodolog
high
sensit
specif
achiev
goal
variou
diagnost
tool
suggest
synthet
peptid
base
diagnost
one
reagent
use
diagnosi
import
viral
diseas
like
aid
infecti
bronchiti
ib
sever
acut
respiratori
syndrom
sar
bluetongu
bt
synthet
peptid
diagnost
reagent
superior
specif
safe
compar
nativ
antigeninactiv
viru
predict
map
b
cell
cell
epitop
usual
perform
use
variou
softwar
like
immun
epitop
databas
iedb
analysi
resourc
http
toolsimmuneepitopeorg
bcpred
b
cell
epitop
predict
server
http
ailabcsiastateedubcpr
hhpred
http
toolkittuebingenmpgdehhpr
predict
analysi
antigen
epitop
mainli
base
differ
algorithm
secondari
structur
predict
hydrophil
plot
flexibl
antigen
index
surfac
probabl
analys
togeth
make
possibl
identifi
immunodomin
epitop
high
reactiv
antibodi
serum
secondari
structur
predict
tool
gener
determin
structur
distribut
antigen
sequenc
comput
procliv
valu
amino
acid
relat
divers
conform
configur
gener
beta
turn
region
chosen
bepitop
predict
basi
predict
probabl
jameson
wolf
develop
method
provid
surfac
contour
valu
call
antigen
index
differ
segment
antigen
suitabl
flexibl
peptid
base
diagnosi
adapt
detect
antibodi
differ
viral
pathogen
human
veterinari
import
like
human
immunodefici
viru
hiv
hepat
c
viru
infecti
bursal
diseas
viru
ibdv
respect
also
differenti
diagnosi
close
relat
agent
like
human
tlymphotrop
viru
htlvi
htlvii
pest
de
petit
rumin
viru
pprv
rinderpest
viru
rp
spite
easi
synthesi
protocol
simpl
sequenc
charact
use
linear
peptid
suffer
practic
difficulti
poor
coat
effici
reactiv
antibodi
ultim
affect
sensit
test
superior
molecular
design
map
form
peptid
dendrim
improv
sensit
elisa
test
use
coat
antigen
multimer
natur
peptid
dendrim
provid
increas
surfacebind
elisa
plate
thu
improv
sensit
improv
epitop
project
tam
zavala
report
superior
map
linear
peptid
bind
plastic
surfac
found
map
gave
effici
surfac
coat
even
littl
concentr
specif
reactiv
monoclon
polyclon
antibodi
comparison
linear
peptid
multimer
form
linear
peptid
show
better
reactiv
mimic
nativ
antigen
structur
therefor
use
success
immunoassay
diagnosi
malaria
infecti
bronchiti
mani
pathogen
hiv
pprv
btv
ibdv
peptid
dendrim
use
serodiagnosi
natur
immun
infect
individu
test
presenc
specif
antibodi
multimer
arrang
dendrimer
peptid
improv
detect
low
affin
antibodi
one
studi
conduct
laboratori
map
show
increas
sensit
elisa
compar
correspond
linear
peptid
well
whole
ibdv
viru
posit
reaction
ie
cutoff
valu
obtain
minimum
amount
map
ngml
comparison
purifi
ibdv
ngml
indic
amount
map
requir
time
lesser
purifi
viru
antigen
elisa
due
higher
bind
effici
map
compar
whole
viru
map
base
enzym
immunoassay
develop
detect
simian
immunodefici
viru
siv
nonhuman
primat
target
region
immunodomin
region
env
gene
use
short
peptid
segment
amino
acid
respect
routin
siv
diagnos
commerci
avail
enzym
immun
assay
western
blot
howev
commerci
method
fail
diagnos
siv
infect
map
base
assay
siv
diagnosi
provid
econom
altern
convent
western
blot
map
base
assay
gave
sensit
specif
detect
infect
differ
lineag
siv
suggest
use
surveil
diseas
map
design
one
epitop
differ
protein
viru
target
one
immunodomin
epitop
multiepitop
map
higher
diagnost
valu
term
mixotop
chimer
map
strategi
found
success
serodiagnosi
hepat
c
viru
gbvc
avoid
complic
design
two
epitop
map
molecul
cocktail
antigenmixotop
differ
map
molecul
individu
epitop
success
use
serodiagnosi
ppr
use
mixtur
differ
linear
peptid
fail
improv
antibodi
detect
case
sar
viru
suggest
interepitop
interact
reason
lower
activ
respect
antigen
perhap
prevent
map
format
document
ppr
differenti
diagnosi
ppr
viru
rp
viru
complic
due
common
epitop
share
morbillivirus
lead
crossreact
serolog
assay
make
interpret
ambigu
synthet
peptid
develop
address
problem
report
approach
use
map
mixotop
cocktail
differ
map
differenti
diagnosi
ppr
rp
virus
present
rp
erad
global
antigen
cross
reactiv
ppr
diagnosi
issu
longer
howev
approach
use
map
peptid
mixotop
may
use
devis
serodiagnosi
immun
cross
reactiv
viral
diseas
veterinari
import
like
west
nile
fever
viru
tick
born
enceph
dengu
viru
blue
tongu
viru
btv
epizoot
haemorrhag
diseas
viru
ehdv
african
hors
sick
viru
immun
cross
reactiv
diseas
whole
viralconvent
antigen
suitabl
antigen
specif
diagnosi
case
highli
antigen
variabl
infect
small
specif
segment
antigen
use
dendrimer
design
better
altern
hyperimmun
sera
rais
map
peptid
dendrim
also
use
serolog
diagnosi
infecti
agent
detect
nativ
antigen
map
form
stabl
macromolecular
antigen
conform
pure
antiserum
rais
map
without
conjug
sever
instanc
immun
sera
rais
map
found
react
cognat
protein
wherea
antisera
rais
correspond
linear
peptid
conjug
protein
carrier
may
interfer
carrier
protein
antibodi
map
antipeptid
antibodi
produc
differ
epitop
segment
protein
ibdv
laboratori
antipeptid
antibodi
demonstr
abil
detect
nativ
viral
antigen
map
differ
peptid
sequenc
ibdv
polypeptid
synthes
peptid
amino
acid
length
use
induct
antibodi
respons
rabbit
specif
serum
viru
detect
comparison
convent
agar
gel
precipit
test
agpt
map
antibodi
base
test
shown
greater
effici
result
suggest
success
use
map
antimap
antibodi
safe
noninfecti
antigen
detect
compar
polyclon
monoclon
antibodi
immun
respons
map
enhanc
supplement
univers
thelper
epitop
human
peptid
region
mer
peptid
segment
amino
acid
n
protein
ppr
viru
found
highli
immunogen
induc
antibodi
specif
pprv
thu
map
offer
superior
design
construct
synthet
peptid
antigen
well
defin
structur
safe
handl
serodiagnosi
use
specif
serum
viral
antigen
detect
reagent
enabl
us
develop
strategi
clinic
diagnosi
viral
diseas
particularli
emerg
reemerg
diseas
better
antigen
nativ
viral
antigen
complet
antigen
provid
protect
respons
well
diagnost
reagent
biosensor
believ
reliabl
sensit
rapid
diagnost
tool
confirmatori
diseas
diagnosi
thu
play
role
diseas
surveil
outbreak
tackl
program
techniqu
potenti
visual
interact
real
time
possibl
labelfre
mode
realtim
biospecif
interact
analysi
bia
measur
ligand
interest
bound
directli
coat
layer
defin
coval
linkag
freeli
access
threedimension
antibodi
interact
interact
directli
detect
measur
chang
surfac
plasmon
reson
spr
signal
method
differ
surfac
interact
techniqu
like
elisa
immunochromatograph
techniqu
biospecif
surfac
spr
chip
easili
regener
permit
seri
measur
perform
repeatedli
surfac
throughput
manner
bia
elimin
need
label
reagent
provid
rapid
onestep
analyt
procedur
better
sensit
assay
also
perform
directli
crude
plasma
sampl
number
biosensor
develop
recent
past
includ
combin
metal
nanoparticl
sens
probe
like
nucleic
acid
pna
peptid
antibodi
major
biosensor
use
gold
nanoparticl
base
detect
system
metal
nanoparticl
like
gold
silver
platinum
iron
oxid
use
easi
handl
provid
easi
differenti
two
sampl
use
peptid
biosensor
technolog
regular
practic
sever
modifi
version
biosensor
avail
use
map
biosensor
technolog
also
well
accept
field
bio
imag
cancer
diagnost
diseas
diagnosi
map
base
biosensor
success
use
detect
hepat
protein
reliabl
sensit
accuraci
effici
map
biosensor
detect
protein
gb
virusc
formerli
known
hepat
g
viru
infect
gbvc
infect
patient
show
promis
clinic
applic
viral
diseas
diagnosi
use
biosensor
base
technolog
simplifi
diseas
diagnosi
collater
studi
exploit
plasmon
coupl
effect
detect
analyt
help
elimin
elabor
diagnost
requir
biomolecul
peptid
use
differ
format
conjunct
nanodevic
diseas
diagnosi
studi
conduct
laboratori
demonstr
possibl
use
map
directli
coat
gold
nanoparticl
detect
bluetongu
antibodi
identifi
immunodomin
epitop
protein
bluetongu
viru
synthes
map
cystein
c
terminu
appli
directli
decor
gold
surfac
detect
viru
antibodi
serum
sampl
nitrocellulos
membran
use
spottest
wherein
presenc
map
specif
antibodi
result
appar
color
chang
cours
map
antibodi
bound
gold
surfac
pink
color
solut
turn
blue
color
spot
addit
made
use
cystein
core
map
well
linear
peptid
ctermin
cystein
direct
coat
gold
surfac
surfac
plasmon
reson
spr
biosensor
platform
antigen
defin
orient
peptid
give
reactiv
btv
antibodi
unpublish
data
approach
involv
conjug
chemistri
gener
requir
antigenantibodi
immobil
spr
platform
also
devis
map
peptid
mixotop
base
serodiagnost
ppr
viru
visual
test
use
map
immunogold
field
diagnosi
strategi
use
map
antigen
specif
antibodi
diagnost
reagent
help
blue
print
address
time
diagnosi
emerg
reemerg
diseas
peptid
dendrim
use
variou
way
tackl
infect
agent
observ
sever
antimicrobi
peptid
synthes
dendrimer
form
show
improv
effici
well
compar
commerci
avail
antibiot
antimicrobi
molecul
case
viral
pathogen
interact
viral
pathogen
host
cell
princip
event
pathogenesi
block
viral
entri
interven
cellular
receptor
remain
first
choic
viral
therapi
part
natur
host
defens
system
mani
peptid
act
inher
antivir
molecul
limit
spread
viral
infect
natur
occur
peptid
defensin
tachyplesin
magnin
lactoferrin
show
antivir
activ
interf
viru
host
interact
basic
defens
mechan
use
antivir
design
aim
restrict
viral
entri
host
cell
achiev
use
synthet
peptid
mimet
viru
bind
site
synthes
viru
bind
site
analog
competit
inhibit
viral
bind
target
tissu
fig
b
respect
act
inhibit
occur
interfac
restrict
viru
primarili
cellular
entri
point
identif
peptid
mimic
pivot
step
phage
display
biopan
techniqu
provid
logic
mean
pinpoint
effici
antivir
peptid
howev
identif
antivir
target
difficult
task
use
combinatori
phage
display
librari
land
identif
mani
potenti
antivir
peptid
identif
mani
virus
like
newcastl
diseas
viru
ndv
rabi
viru
hepat
viru
antivir
peptid
mostli
use
two
form
linearcycl
form
favor
multimer
form
linear
andor
cyclic
form
peptid
use
antivir
studi
ndv
rabi
howev
presenc
multipl
bind
site
singl
viral
particl
practic
need
larg
number
neutral
peptid
may
limit
applic
shortfal
antivir
peptid
strategi
bridg
devis
multimer
design
hall
et
al
report
improv
antivir
effici
antihantaviru
peptid
use
multimer
form
anticip
use
multival
inhibitor
may
disrupt
polyval
interact
recent
donalisio
et
al
report
success
use
dendrimer
heparinsulf
bind
peptid
inhibit
infect
genit
type
human
papillomaviru
studi
shown
tetrabranch
compound
deriv
abl
inhibit
replic
genit
type
human
papillomaviru
keratocarcinona
cell
luganini
et
al
show
antivir
activ
human
cytomegaloviru
primari
fibroblast
endotheli
cell
anoth
studi
group
util
peptid
inhibit
herp
simplex
viru
type
replic
invitro
studi
show
potenti
applic
superior
peptid
organ
antivir
intervent
possibl
viral
therapi
time
progress
made
understand
viru
pathogenesi
subsequ
event
happen
cell
viru
life
cycl
may
provid
tool
interven
event
use
map
peptid
better
way
vaccin
favor
strategi
diseas
control
program
gener
heat
kill
live
attenu
vaccin
use
regim
howev
vaccin
suffer
inher
drawback
revers
pathogenesi
limit
protect
subunit
vaccin
consist
either
whole
recombin
protein
synthet
peptid
coin
altern
classic
vaccin
similarli
immunodomin
epitop
use
synthes
peptid
base
vaccin
give
rel
flexibl
term
bulk
peptid
synthesi
proven
chemic
stabil
mani
time
linear
peptid
show
poor
immun
respons
reactiv
limit
practic
applic
potenti
vaccin
superior
synthet
design
map
peptid
dendrim
provid
contemporari
vaccin
model
import
viral
diseas
anim
howev
challeng
remain
put
requir
protect
epitop
b
cell
epitop
one
singl
map
molecul
map
use
two
design
homotrop
multim
one
epitop
hererotrop
combin
differ
epitop
later
synthesi
difficult
design
prove
high
chemic
stabil
retain
immunolog
properti
act
surrog
antigen
requir
induct
protect
viral
invas
prefer
map
tetramer
octamer
construct
howev
larger
construct
also
use
mozdzanowska
et
al
report
success
use
peptid
map
th
determin
immuneprophylact
applic
influenza
type
challeng
mice
use
determin
peptid
show
high
reactiv
mab
suggest
nativ
antigen
natur
fix
viral
protein
howev
effect
deliveri
map
improv
antigen
process
essenti
main
drive
forc
develop
hybrid
map
design
liposom
entrap
haro
et
al
studi
aspect
map
base
immun
use
tetramer
heterogen
palmitoylderiv
map
gene
hepat
viru
use
lipopeptid
dendrim
also
studi
fmd
viru
lipopeptid
map
antigen
elimin
use
adjuv
vaccin
thu
make
better
altern
immun
use
map
base
mimotop
induc
respiratori
syncyti
viru
rsv
specif
antimimotop
antibodi
ctl
respons
suggest
possibl
applic
vaccin
rsv
along
initi
studi
map
base
peptid
vaccin
design
continu
evolv
improv
mount
immun
respons
better
protect
profil
advanc
peptid
chemistri
combin
nanodesign
drastic
improv
perform
map
base
vaccin
widen
biomed
applic
recent
map
base
vaccin
research
use
combin
synthet
approach
size
depend
nanomateri
includ
peptid
selfassembl
nanoparticl
lipophil
moieti
gold
nanoparticl
nonpeptid
base
dendrimer
molecul
studi
also
use
cell
penetr
peptid
induct
cell
mediat
respons
superior
map
design
improv
immun
respons
induct
also
help
safer
deliveri
biggest
hurdl
case
dna
vaccin
nanoparticl
coat
map
provid
easi
cellular
deliveri
use
therapeut
vaccin
peptid
dendrim
base
vaccin
contain
cell
epitop
branch
multipl
b
cell
epitop
increas
immunereact
cover
cmi
hmi
design
success
candid
vaccin
report
cubillo
et
al
result
studi
show
potenti
system
immun
respons
also
demonstr
mucos
immun
respons
iga
product
point
use
peptid
dendrim
marker
vaccin
dendrimer
modul
combin
cell
b
cell
epitop
also
use
vaccin
develop
classic
swine
fever
csf
viru
wherein
three
differ
b
cell
epitop
region
cover
region
construct
respect
protein
csf
viru
select
cell
epitop
protein
cover
amino
acid
region
three
construct
use
first
construct
found
effect
assess
elispot
assay
highest
valu
produc
cell
csfv
challeng
increas
secret
cell
product
believ
characterist
csf
infect
recent
time
multi
epitop
candid
vaccin
hepat
c
develop
includ
nonstructur
protein
epitop
candid
vaccin
contain
epitop
core
protein
hepat
c
viru
studi
two
approach
use
map
design
first
one
amino
acid
length
two
ctl
epitop
second
one
map
amino
acid
design
th
epitop
two
ctl
epitop
ly
use
linker
epitop
join
candid
vaccin
elicit
cellular
immunogen
induct
respons
spite
sever
advantag
map
base
vaccin
product
emerg
market
type
vaccin
cover
discontinu
epitop
thu
offer
limit
neutral
mani
case
anoth
practic
limit
deliveri
biostabl
peptid
vaccin
howev
limit
overcom
use
lipophil
domain
conjug
peptid
better
antigen
nativ
viral
antigen
complet
antigen
provid
protect
respons
well
diagnost
reagent
howev
pathogen
cross
reactiv
issu
associ
nativ
antigen
continu
deriv
research
area
develop
safe
specif
altern
antigen
develop
subunit
synthet
peptid
antigen
subunit
synthet
peptid
antigen
linear
map
format
applic
specif
diagnost
reagent
face
limit
elicit
protect
immun
respons
possibl
nativ
antigen
mani
attempt
made
toward
develop
subunit
synthet
peptid
vaccin
limit
success
amelior
peptid
design
discuss
review
provid
possibl
prophylact
confirm
diagnost
strategi
along
wholesom
therapeut
altern
thu
provid
comb
ground
success
tackl
emerg
reemerg
viral
diseas
global
concern
today
collect
applic
supramolecular
design
peptid
may
provid
viabl
rescu
variou
viral
infect
target
viru
stage
life
cycl
better
manag
emerg
reemerg
diseas
